Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaki Ri

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Scientific Reports|April 25, 2025
Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malignant lymphomaHideki Goto, Masashi Sawa, Shin-Ichiro Fujiwara, et al.
Future Oncology (London, England)|February 29, 2024
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study)Yu Abe, Shiro Kubonishi, Masaki Ri, et al.
Cancer Science|November 27, 2025
Targeting Overexpressed IDO in Stromal Cells as a Potential Therapeutic Strategy in Multiple MyelomaToru Ebina, Masaki Ri, Yoshiaki Marumo, et al.
European Journal of Haematology|November 6, 2013
Antitumor effects of bevacizumab in a microenvironment-dependent human adult T-cell leukemia/lymphoma mouse modelFumiko Mori, Takashi Ishida, Asahi Ito, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 2021
Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myelomaMitsuhito Hirano, Yoichi Imai, Yuta Kaito, et al.
Hematological Oncology|November 26, 2022
Anti-CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs studyKazutaka Sunami, Shin-Ichi Fuchida, Kenshi Suzuki, et al.
Ejhaem|July 18, 2022
Clinical features of anthracycline-induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single-center, retrospective observational studyTakafumi Nakayama, Yoshiko Oshima, Shigeru Kusumoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2015
Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/LymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
Blood|June 25, 2017
Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphomaTomoko Narita, Takashi Ishida, Asahi Ito, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2015
[Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma]Ayako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Scientific Reports|April 25, 2025
Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malignant lymphomaHideki Goto, Masashi Sawa, Shin-Ichiro Fujiwara, et al.
Future Oncology (London, England)|February 29, 2024
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study)Yu Abe, Shiro Kubonishi, Masaki Ri, et al.
Cancer Science|November 27, 2025
Targeting Overexpressed IDO in Stromal Cells as a Potential Therapeutic Strategy in Multiple MyelomaToru Ebina, Masaki Ri, Yoshiaki Marumo, et al.
European Journal of Haematology|November 6, 2013
Antitumor effects of bevacizumab in a microenvironment-dependent human adult T-cell leukemia/lymphoma mouse modelFumiko Mori, Takashi Ishida, Asahi Ito, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 2021
Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myelomaMitsuhito Hirano, Yoichi Imai, Yuta Kaito, et al.
Hematological Oncology|November 26, 2022
Anti-CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs studyKazutaka Sunami, Shin-Ichi Fuchida, Kenshi Suzuki, et al.
Ejhaem|July 18, 2022
Clinical features of anthracycline-induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single-center, retrospective observational studyTakafumi Nakayama, Yoshiko Oshima, Shigeru Kusumoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2015
Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/LymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
Blood|June 25, 2017
Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphomaTomoko Narita, Takashi Ishida, Asahi Ito, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2015
[Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma]Ayako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
Pageof 12